Andlauer Healthcare Group (AND) AI Stock Analysis

• Market Cap: $2.10B
• Dividend Yield: 0.82%
• Average Volume (3M): 109.80K
• Price to Earnings (P/E): 30.4
• Beta (1Y): 0.67
• Revenue Growth: 1.72%
• EPS Growth: 13.48%
• Country: CA
• Employees: 2,380
• Sector: Healthcare
• Sector Strength: 46
• Industry: Integrated Freight & Logistics
• EPS (TTM): 0.38
• Shares Outstanding: 18,377,054
• 10 Day Avg. Volume: 232,902
• 30 Day Avg. Volume: 109,799
• PEG Ratio: -39.74
• Price to Book (P/B): 3.71
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 14.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $56.00
• Price Target Upside: 4.67% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4

Andlauer Healthcare Group's overall stock score is driven by its strong financial performance and positive corporate events. However, the technical analysis suggests caution due to overbought signals, and the stock appears overvalued, which tempers the overall score. The UPS acquisition provides a significant premium, enhancing shareholder value.

Positive Factors

Geographical Performance

Canada ground offsets ongoing U.S. challenges, indicating some geographical areas are performing well, potentially supporting stock value.

Strategic Positioning

Well-positioned to capitalize on a period suggests strategic opportunities could positively influence stock performance.

Negative Factors

Earnings

Q1/25 EPS miss highlights earnings underperformance, which could lead to negative sentiment around the stock.

Financial Performance

Q1/25 results miss on elevated retail bad debt expenses, indicating financial struggles that could negatively impact stock.

Seasonal Impact

Seasonally weak quarter impacted results, suggesting that seasonal factors might be a challenge for stock performance.

Andlauer Healthcare Group Business Overview & Revenue Model

Company Description

Andlauer Healthcare Group (AND) is a leading Canadian company that specializes in providing customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. The company operates across several sectors, including pharmaceuticals, biologics, and medical devices, offering a range of services that include transportation, warehousing, and distribution tailored to meet the stringent regulations and requirements of the healthcare industry.

How the Company Makes Money

Andlauer Healthcare Group makes money primarily through its comprehensive suite of logistics and transportation services designed specifically for the healthcare industry. Key revenue streams include specialized transportation services, which involve the secure and compliant movement of healthcare products, and logistics and distribution services, which encompass warehousing, inventory management, and distribution solutions. The company leverages strategic partnerships and long-term contracts with healthcare manufacturers and distributors, ensuring a steady flow of revenue. Their expertise in adhering to regulatory standards and providing reliable, timely delivery services further enhances their competitive edge in the industry.

Andlauer Healthcare Group Financial Statement Overview

Summary

Andlauer Healthcare Group shows strong financial health with efficient operations and a solid cash flow position. The income statement and cash flow metrics are commendable, though the balance sheet suggests moderate leverage which should be monitored.

Income Statement

The company displays strong profitability with a consistently positive gross profit margin. The net profit margin shows moderate stability, but there was a slight decline in revenue growth rate recently, indicating potential challenges in sustaining top-line growth. EBIT and EBITDA margins remain healthy, suggesting efficient operational management.

Balance Sheet

The balance sheet reveals a solid equity base with a moderate debt-to-equity ratio, indicating manageable leverage. Return on Equity (ROE) is positive, demonstrating effective use of equity to generate profits. However, the equity ratio reflects a moderate reliance on debt financing, which could pose risks if market conditions change.

Cash Flow

The company exhibits robust cash flow management with a healthy operating cash flow to net income ratio, and significant free cash flow generation. Free cash flow to net income ratio is strong, but the growth rate of free cash flow has seen some variation, suggesting potential fluctuations in cash availability for reinvestment and debt servicing.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
650.48M	647.95M	648.42M	440.12M	314.34M
	Gross Profit
147.20M	147.48M	158.85M	110.75M	79.55M
	EBIT
93.96M	96.05M	110.34M	73.70M	50.94M
	EBITDA
166.72M	166.96M	175.07M	154.91M	79.20M
	Net Income Common Stockholders
64.47M	66.14M	76.28M	89.95M	37.71M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
40.48M	59.74M	65.86M	24.99M	30.15M
	Total Assets
696.92M	682.43M	712.46M	644.17M	252.80M
	Total Debt
181.21M	127.90M	163.29M	187.25M	129.61M
	Net Debt
140.73M	68.16M	97.43M	162.26M	99.47M
	Total Liabilities
265.78M	212.86M	271.47M	292.05M	158.47M
	Stockholders Equity
431.13M	469.57M	440.99M	352.12M	94.33M
Cash Flow		Free Cash Flow
104.02M	78.83M	109.17M	74.42M	45.56M
	Operating Cash Flow
124.40M	104.42M	137.13M	84.09M	51.00M
	Investing Cash Flow
-18.86M	-23.85M	-45.56M	-183.38M	-20.37M
	Financing Cash Flow
-126.24M	-86.18M	-51.59M	93.89M	-19.20M

Andlauer Healthcare Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 53.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AND, the sentiment is Positive. The current price of 53.5 is above the 20-day moving average (MA) of 48.53, above the 50-day MA of 42.89, and above the 200-day MA of 42.01, indicating a bullish trend. The MACD of 3.46 indicates Negative momentum. The RSI at 82.04 is Negative, neither overbought nor oversold. The STOCH value of 69.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:AND.

Andlauer Healthcare Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COV	79 Outperform	C$72.11M	14.27	19.57%	―	38.28%	―
DR	70 Outperform	$339.51M	2.44	33.87%	2.39%	-29.54%	667.77%
GUD	65 Neutral	$567.85M	51.49	1.41%	―	12.21%	―
AND	64 Neutral	$2.10B	30.43	15.10%	0.82%	1.72%	13.48%
BHC	54 Neutral	$2.42B	―	3.60%	―	11.87%	91.09%
Sector *	52 Neutral	$5.15B	3.56	-42.52%	2.83%	14.56%	-0.50%

Andlauer Healthcare Group Corporate Events

Andlauer Healthcare Group Confirms Director Elections and Auditor Appointment

At its annual shareholders’ meeting, Andlauer Healthcare Group announced the election of all nominated directors and the appointment of KPMG LLP as auditors for the 2025 fiscal year. This reinforces AHG’s governance and operational continuity, potentially strengthening its market position and stakeholder confidence.

Spark’s Take on TSE:AND Stock

According to Spark, TipRanks’ AI Analyst, TSE:AND is a Neutral.

Andlauer Healthcare Group shows strong financial performance, backed by solid cash flow and operational efficiency. Significant corporate events, including the UPS acquisition, offer promising growth potential. However, technical analysis indicates caution due to overbought signals, and the stock appears overvalued, which tempers the overall score.

To see Spark’s full report on TSE:AND stock, click here.

Andlauer Healthcare Group Announces Q1 2025 Results and UPS Acquisition

Andlauer Healthcare Group reported a 3.1% increase in revenue for Q1 2025, driven by organic growth in its Canadian operations, despite reduced contributions from its US-based truckload businesses. The company entered a joint venture with NowPac to enhance its packaging services and announced a definitive agreement for acquisition by UPS in an all-cash transaction valued at approximately $2.2 billion, which is expected to provide immediate value to shareholders.

Spark’s Take on TSE:AND Stock

According to Spark, TipRanks’ AI Analyst, TSE:AND is a Outperform.

Andlauer Healthcare Group scores well due to strong financial performance, particularly in cash flow management and profitability. The recent corporate events further bolster its position by highlighting growth opportunities and shareholder value. However, technical analysis is moderate with no strong signals, and the valuation suggests the stock may be overvalued, which tempers the overall score.

To see Spark’s full report on TSE:AND stock, click here.

UPS to Acquire Andlauer Healthcare Group in C$2.2 Billion Deal

Andlauer Healthcare Group (AHG) is set to be acquired by UPS in an all-cash transaction valued at approximately C$2.2 billion, offering AHG shareholders a significant premium over recent trading prices. This acquisition will integrate AHG into the UPS Healthcare global network, enhancing UPS’s capabilities in providing complex end-to-end solutions for healthcare logistics. The transaction is supported by AHG’s leadership and is expected to strengthen UPS’s presence in Canada, while providing immediate value to AHG’s shareholders and ensuring continued growth opportunities for AHG employees.

Spark’s Take on TSE:AND Stock

According to Spark, TipRanks’ AI Analyst, TSE:AND is a Outperform.

Andlauer Healthcare Group scores well due to strong financial performance, particularly in cash flow management and profitability. The recent corporate events further bolster its position by highlighting growth opportunities and shareholder value. However, technical analysis is moderate with no strong signals, and the valuation suggests the stock may be overvalued, which tempers the overall score.

To see Spark’s full report on TSE:AND stock, click here.

Andlauer Healthcare Group Declares First Quarter Dividend

Andlauer Healthcare Group Inc. announced a first quarter dividend of $0.12 per share, payable on April 15, 2025, to shareholders of record as of March 31, 2025. This announcement underscores the company’s financial health and commitment to returning value to its shareholders, reinforcing its strong position in the healthcare logistics and transportation industry.

Andlauer Healthcare Group Forms Joint Venture with NowPac

Andlauer Healthcare Group has announced a joint venture between its packaging subsidiary, Nova Pack, and NowPac, a Toronto-based company specializing in contract packaging services for the healthcare sector. This collaboration aims to leverage technology, automation, and AHG’s extensive healthcare supply chain network to offer enhanced contract packaging solutions. The joint venture, equally owned by AHG’s Accuristix and NowPac’s owners, is expected to boost AHG’s cash flow and earnings per share immediately. By combining NowPac’s expertise in packaging with AHG’s logistics capabilities, the partnership is set to enhance efficiency and scalability in healthcare supply chain solutions, providing significant growth opportunities and value for customers.

Andlauer Healthcare Group Reports Stable 2024 Financial Results Amid Market Challenges

Andlauer Healthcare Group reported its financial results for Q4 2024 and the full fiscal year, showing slight declines in revenue and operating income compared to the previous year. Despite facing challenges in its US-based truckload businesses, the company experienced growth in its Canadian transportation network and packaging solutions. The company’s low debt levels and strong cash generation provide financial flexibility for future growth opportunities, including share buybacks and capital allocation to enhance value for customers and shareholders.